Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Martin Moylan
ST. PAUL, Minn.

Minnesota businesses attracting less venture capital

Go Deeper.

Create an account or log in to save stories.

Log inCreate a free Account

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Show me!

Young Minnesota companies are having a harder time raising money from investors.

So-called venture funding in Minnesota is expected to be down this year compared to 2012, according to new data from the quarterly MoneyTree survey. Investors appear to have cooled on the medical device industry, which typically gets the lion's share of venture dollars in Minnesota.

Start-up medtech firms nationwide aren't providing attractive returns for investors, said Shaye Mandle, executive vice president with LifeScience Alley, the state's medical device industry trade group.

"Over the past three years, we've seen venture capital investment in medtech drop by more than 50 percent," Mandle said. "We're starting to see a little bit of an uptick," Mandle said.

For years, Minnesota companies got more than 1 percent of total U.S. venture capital investments. But the state hasn't topped that mark since 2009.

Minnesota companies attracted about $84 million in venture capital during the third quarter, according to the MoneyTree report. Venture funding for the year is on pace to fall below the 2012 total of $250 million.

"Returns on investment in the venture arena for medical technology over the last ten years have been quite flat," said Mandle. "So, for investors looking to invest in sectors to maximize returns, medtech just hasn't been a great investment."